Jia-Ray Yu

Dr. Jia-Ray Yu serves as Assistant Professor at the Fralin Biomedical Research Institute at VTC and Adjunct Assistant Professor at Children's National Research Institute, with additional appointments in the Virginia-Maryland College of Veterinary Medicine. His research program investigates chromatin-level gene expression regulation and its dysregulation in human cancers, particularly pediatric brain malignancies.

Dr. Yu's educational background includes:

• Ph.D. in Genetics from Stony Brook University, Cold Spring Harbor Laboratory
• B.S. in Biological Science and Technology from National Chiao Tung University, Taiwan

His laboratory employs integrated methodologies in chromatin biochemistry, deep-sequencing, and cancer biology to explore how chromatin-modifying enzymes drive oncogenesis. Current research focuses on protein-RNA/protein interactions regulating chromatin modifiers, heterochromatin-euchromatin imbalance in pediatric gliomas, and non-histone targets of histone-modifying enzymes. This work bridges fundamental epigenetic mechanisms with therapeutic applications for aggressive cancers.

Analysis of recent publications reveals consistent emphasis on allosteric regulation of chromatin complexes (NSD1, PRC2) and their pathological roles in H3K27M-mutant diffuse midline gliomas. The research demonstrates strong translational focus on epigenetic vulnerabilities in pediatric brain cancers through molecular and biochemical approaches.

Dr. Yu has received significant recognition:

• Emerging Scientist Award, Children's Cancer Research Fund (2022)
• Children's Cancer Foundation Research Award (2022)
• CURE Childhood Cancer Award (2022)
• iTHRIV Scholars Career Development Award (2022)
• American Cancer Society Postdoctoral Fellowship (2017-2020)

While specific grant details are not provided in available materials, Dr. Yu's research program demonstrates strong institutional support through multiple concurrent appointments and active laboratory operations. His work has generated significant media attention regarding pediatric brain cancer mechanisms and rare disease research.

The Yu Lab operates from the Cancer Research Center at Children's National Research & Innovation Campus in Washington, D.C., maintaining active collaborations across Virginia Tech, Children's National Hospital, and the broader cancer research community. Current research directions emphasize mechanistic studies of chromatin dysregulation with direct implications for therapeutic development in pediatric oncology.